SB431542 drug
Evidence from:
primary |
all sources
Related entities (8)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| endophenotype | associated_with | SB431542 | — | 1 |
| endophenotype | biomarker_for | SB431542 | — | 1 |
| SB431542 | associated_with | brain | — | 1 |
| SB431542 | interacts_with | externalizing behavior | — | 1 |
| SB431542 | interacts_with | KSR medium | — | 1 |
| SB431542 | associated_with | KSR medium | — | 1 |
| SB431542 | interacts_with | N2 medium | — | 1 |
| SB431542 | targets | TGFβ | — | 1 |
Mentioned in (9)
Papers in which this entity is mentioned.
- Multi-omic quantitative trait loci link tandem repeat size variation to gene regulation in human brain. (2025)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease. (2020)
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. (2018)
- Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations. (2017)
- Single-Cell Profiling of an In Vitro Model of Human Interneuron Development Reveals Temporal Dynamics of Cell Type Production and Maturation. (2017)
- Sustained synchronized neuronal network activity in a human astrocyte co-culture system. (2016)
- Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. (2016)
- Modeling hippocampal neurogenesis using human pluripotent stem cells. (2014)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| sb431542 | drug | 9 | 22 |
| sb | drug | — | — |
| tgfβ inhibitor sb431542 | drug | — | — |